Global Perceptions and Utilization of Clinical Neurophysiology in Movement Disorders

作者：Panagiotis Kassavetis, Robert Chen, Christos Ganos, Mark Hallett, Masashi Hamada, Anna Latorre, Pramod Kumar Pal, Petra Schwingenschuh, Felipe Vial, Marina A.J. Tijssen, Shabbir Hussain I. Merchant · 发表于：Movement Disorders Clinical Practice · 年份：2024 · DOI：10.1002/mdc3.13974 · 被引用次数：10 · 研究领域：Neurological disorders and treatments、Parkinson's Disease Mechanisms and Treatments、Transcranial Magnetic Stimulation Studies

BACKGROUND: Clinical neurophysiology (CNP) involves the use of neurophysiological techniques to make an accurate clinical diagnosis, to quantify the severity, and to measure the treatment response. Despite several studies showing CNP to be a useful diagnostic tool in Movement Disorders (MD), its more widespread utilization in clinical practice has been limited. OBJECTIVES: To better understand the current availability, global perceptions, and challenges for implementation of diagnostic CNP in the clinical practice of MD. METHODS: The International Parkinson and Movement Disorders Society (IPMDS) formed a Task Force on CNP. The Task Force distributed an online survey via email to all the members of the IPMDS between August 5 and 30, 2021. Descriptive statistics were used for analysis of the survey results. Some results are presented by IPMDS geographical sections namely PanAmerican (PAS), European (ES), African (AFR), Asian and Oceanian (AOS). RESULTS: Four hundred and ninety-one IPMDS members (52% males), from 196 countries, responded. The majority of responders from the AFR (65%) and PAS (63%) sections had no formal training in diagnostic CNP (40% for AOS and 37% for ES). The most commonly used techniques are electroencephalography (EEG) (72%) followed by surface EMG (71%). The majority of responders think that CNP is somewhat valuable or very valuable in the assessment of MD. All the sections identified "lack of training" as one of the biggest challenges for diagnostic CNP ...